- Home
- PHVS vs AMAL Comparison
PHVS vs AMAL Comparison
Compare PHVS & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- AMAL
- Stock Information
- Founded
- PHVS 2015
- AMAL 1923
- Country
- PHVS Switzerland
- AMAL United States
- Employees
- PHVS N/A
- AMAL N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- AMAL Commercial Banks
- Sector
- PHVS Health Care
- AMAL Finance
- Exchange
- PHVS Nasdaq
- AMAL Nasdaq
- Market Cap
- PHVS 980.3M
- AMAL 937.6M
- IPO Year
- PHVS 2021
- AMAL 2018
- Fundamental
- Price
- PHVS $18.00
- AMAL $33.07
- Analyst Decision
- PHVS Buy
- AMAL Buy
- Analyst Count
- PHVS 6
- AMAL 2
- Target Price
- PHVS $37.17
- AMAL $38.50
- AVG Volume (30 Days)
- PHVS 35.9K
- AMAL 195.3K
- Earning Date
- PHVS 08-13-2025
- AMAL 07-24-2025
- Dividend Yield
- PHVS N/A
- AMAL 1.69%
- EPS Growth
- PHVS N/A
- AMAL 9.81
- EPS
- PHVS N/A
- AMAL 3.36
- Revenue
- PHVS N/A
- AMAL $303,970,000.00
- Revenue This Year
- PHVS N/A
- AMAL $11.72
- Revenue Next Year
- PHVS N/A
- AMAL $12.48
- P/E Ratio
- PHVS N/A
- AMAL $9.85
- Revenue Growth
- PHVS N/A
- AMAL 7.13
- 52 Week Low
- PHVS $11.51
- AMAL $25.03
- 52 Week High
- PHVS $25.50
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- PHVS 55.25
- AMAL 67.43
- Support Level
- PHVS $16.72
- AMAL $31.13
- Resistance Level
- PHVS $17.53
- AMAL $33.53
- Average True Range (ATR)
- PHVS 0.99
- AMAL 0.73
- MACD
- PHVS 0.07
- AMAL 0.26
- Stochastic Oscillator
- PHVS 66.67
- AMAL 88.50
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.